Vatanidipine

CAS No. 116308-55-5

Vatanidipine( —— )

Catalog No. M34043 CAS No. 116308-55-5

Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 730 In Stock
5MG 454 In Stock
10MG 621 In Stock
25MG 941 In Stock
50MG 1237 In Stock
100MG 1628 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Vatanidipine
  • Note
    Research use only, not for human use.
  • Brief Description
    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
  • Description
    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116308-55-5
  • Formula Weight
    686.8
  • Molecular Formula
    C41H42N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OCCC1=CC=C(C=C1)N2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)(=O)C=5C(C(C(OC)=O)=C(C)NC5C)C6=CC(N(=O)=O)=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ziconotide Acetate

    Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.

  • CALP3

    Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site. Activates phosphodiesterase in the absence of Ca2+ and inhibits Ca2+-mediated cytotoxicity and apoptosis (IC50 = 33 μM).

  • Darodipine

    Darodipine is a dihydropyridine type Ca+2 antagonist.